Table 3.
C57.0 Fallopian tube |
C56.9 Ovary |
|||
---|---|---|---|---|
Characteristic | No. | % (95% CI) | No. | % (95% CI) |
In situ | 164 | 97.9 (93.7 to 99.3) | ||
<50 y | 61 | 100 | ||
50+ y | 103 | 96.8 (90.3 to 98.9) | ||
Early-stage/low-grade serous | 106 | 83.4 (72.3 to 90.3) | 1247 | 90.7 (88.7 to 92.3) |
<50 y | <16 | —† | 394 | 96.3 (93.6 to 97.9) |
50+ y | 91 | 84.3 (72.5 to 91.3) | 853 | 88.1 (85.4 to 90.3) |
Early-stage/high-grade serous | 357 | 83.2 (77.3 to 87.7) | 1198 | 85.2 (82.7 to 87.4) |
<50 y | 45 | 80.4 (58.7 to 91.5) | 230 | 88.4 (82.6 to 92.4) |
50+ y | 312 | 83.8 (77.6 to 88.4) | 968 | 84.4 (81.5 to 86.9) |
Late-stage/low-grade serous | 218 | 42.1 (34.1 to 49.9) | 8001 | 46.1 (44.9 to 47.3) |
<50 y | 27 | 52.2 (30.1 to 70.3) | 1974 | 63.5 (61.0 to 65.8) |
50+ y | 191 | 40.6 (32.0 to 49.0) | 6027 | 40.5 (39.1 to 41.8) |
Late-stage/high-grade serous | 1605 | 44.5 (41.1 to 47.7) | 29 685 | 33.8 (33.2 to 34.4) |
<50 y | 166 | 58.7 (48.0 to 67.9) | 4358 | 44.0 (42.2 to 45.7) |
50+ y | 1439 | 42.7 (39.2 to 46.2) | 25 327 | 32.0 (31.3 to 32.7) |
Cause of death was defined as fallopian tube cancer or ovarian cancer, respectively, using the Surveillance, Epidemiology, and End Results cause-specific death classification variable (21). Cancer cases were excluded if not first tumor, if missing age at diagnosis, or if follow-up was missing or 0. CI = confidence interval.
Cell count <16, frequencies, and percent surviving are not reported.